NEWCELX LTD

NCEL · NASDAQ

Updated at 2026-11-16 21:36:43

$2.75+5.36%
Today's High
$2.75
Today’s Low
$2.61
NEWCELX LTD (NCEL) Stock Price & Market Data
Search empty state illustration
...

Candlestick trends are for reference. Refer to the trading page for actual data.

Key Statistics

Previous Open
$2.70
Previous Close
$2.61
Volume
12.04K
Market Cap
$15.07M
P/E Ratio
--
EPS
$-1.32

Previous Day Range

$2.55$2.70

52-Week Range

$1.82$5.12

Company Overview

Sector
HEALTHCARE
Industry
Biotechnology
Sub-industry
BIOTECHNOLOGY
Headquarters
HOHSTRASSE 1, KLOTEN, SWITZERLAND, 8302
Country
CH
Listing Date
2021-01-29
Fiscal Year End
December
Shares Outstanding
5.38M
CIK
0001783036

NewcelX Ltd., a biotechnology company, engages in developing transformative cell-based and small-molecule therapies for neurodegenerative and metabolic diseases. The company is headquartered in Zurich, Switzerland.

Financial Metrics

Revenue

2026-06-30

--

2026-03-31

--

2025-09-30

--

2025-03-31

--

Operating Expenses

2026-06-30

$2.8M

2026-03-31

$4.09M

2025-09-30

$1.77M

2025-03-31

$1.58M

Net Income

2026-06-30

-$2.9M

2026-03-31

$4.34M

2025-09-30

-$2.22M

2025-03-31

$55.02K

Net Profit Margin

2026-06-30

--

2026-03-31

--

2025-09-30

--

2025-03-31

--

Earnings Per Share

2026-06-30

--

2026-03-31

--

2025-09-30

$-1.05

2025-03-31

$-0.99

Earnings Before Interest, Taxes, Depreciation, and Amortization

2026-06-30

-$2.8M

2026-03-31

-$1.02M

2025-09-30

-$2.21M

2025-03-31

-$1.58M

Effective Tax Rate

2026-06-30

--

2026-03-31

1.3%

2025-09-30

--

2025-03-31

--

FAQs

Risk Warning

Stock prices can be highly volatile and may rise or fall sharply in a short period. Digital asset and derivative products involve additional risks such as leverage and liquidity. Content on this page is for reference only and does not constitute investment advice. Product availability and access may vary by region and applicable regulations.